髓过氧化物酶为多发性骨髓瘤进展创造允许性微环境生态位
研究在多发性骨髓瘤小鼠模型中发现,肿瘤早期骨髓CD11b+髓系细胞增多且Mpo表达升高,MPO通过诱导关键生长因子促进肿瘤增殖并抑制细胞毒性T细胞活性;使用MPO小分子不可逆抑制剂4-ABAH治疗的小鼠总体骨髓瘤肿瘤负荷显著降低。
要点
- 骨髓瘤早期骨髓CD11b+髓系细胞和Mpo表达增加,肿瘤细胞归巢偏向髓系细胞多和MPO活性高的部位。
- MPO诱导关键骨髓瘤生长因子表达,促进肿瘤细胞增殖并抑制细胞毒性T细胞活性。
- MPO不可逆抑制剂4-ABAH治疗的小鼠总体骨髓瘤肿瘤负荷显著降低。
核心结论
- MPO促进多发性骨髓瘤肿瘤生长,MPO特异性抑制剂可能为限制骨髓瘤疾病进展提供新的治疗策略。
研究设计与样本
- 研究采用5TGM1-KaLwRij小鼠骨髓瘤模型,评估MPO在多发性骨髓瘤发病中的作用及药物抑制MPO阻碍疾病进展的能力。
主要发现
- 在5TGM1-KaLwRij小鼠骨髓瘤模型中,肿瘤发展早期与骨髓CD11b+髓系细胞群增加及骨髓内Mpo表达升高相关。
- 骨髓瘤肿瘤细胞向骨髓内髓系细胞数量增多和MPO活性升高的部位归巢增加。
- MPO诱导关键骨髓瘤生长因子表达,导致肿瘤细胞增殖并抑制细胞毒性T细胞活性。
- 使用MPO小分子不可逆抑制剂4-ABAH治疗的小鼠,总体骨髓瘤肿瘤负荷显著降低。
临床怎么用
- 原文结论提出MPO特异性抑制剂可能为限制多发性骨髓瘤疾病进展提供新的治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Expression of myeloperoxidase (MPO), a key inflammatory enzyme restricted to myeloid cells, is negatively associated with the development of solid tumours. Activated myeloid cell populations are increased in multiple myeloma (MM); however, the functional consequences of myeloid-derived MPO within the myeloma microenvironment are unknown. Here, the role of MPO in MM pathogenesis was investigated, and the capacity for pharmacological inhibition of MPO to impede MM progression was evaluated. In the 5TGM1-KaLwRij mouse model of myeloma, the early stages of tumour development were associated with an increase in CD11b+ myeloid cell populations and an increase in Mpo expression within the bone marrow (BM). Interestingly, MM tumour cell homing was increased towards sites of elevated myeloid cell numbers and MPO activity within the BM. Mechanistically, MPO induced the expression of key MM growth factors, resulting in tumour cell proliferation and suppressed cytotoxic T-cell activity. Notably, tumour growth studies in mice treated with a small-molecule irreversible inhibitor of MPO (4-ABAH) demonstrated a significant reduction in overall MM tumour burden. Taken together, our data demonstrate that MPO contributes to MM tumour growth, and that MPO-specific inhibitors may provide a new therapeutic strategy to limit MM disease progression.
引用
- Williams CMD, Noll JE, Bradey AL, et al. Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma. Br J Haematol. 2023. PMID: 37699574. doi:10.1111/bjh.19102
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。